Senzime Past Earnings Performance

Past criteria checks 0/6

Senzime's earnings have been declining at an average annual rate of -35.7%, while the Medical Equipment industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 37.4% per year.

Key information

-35.7%

Earnings growth rate

-25.8%

EPS growth rate

Medical Equipment Industry Growth6.2%
Revenue growth rate37.4%
Return on equity-35.7%
Net Margin-375.2%
Next Earnings Update07 May 2024

Recent past performance updates

Recent updates

Will Senzime (STO:SEZI) Spend Its Cash Wisely?

Feb 20
Will Senzime (STO:SEZI) Spend Its Cash Wisely?

We Think Senzime (STO:SEZI) Can Afford To Drive Business Growth

Sep 01
We Think Senzime (STO:SEZI) Can Afford To Drive Business Growth

Companies Like Senzime (STO:SEZI) Are In A Position To Invest In Growth

May 18
Companies Like Senzime (STO:SEZI) Are In A Position To Invest In Growth

How Much Of Senzime AB (publ) (STO:SEZI) Do Insiders Own?

Mar 15
How Much Of Senzime AB (publ) (STO:SEZI) Do Insiders Own?

Shareholders of Senzime (STO:SEZI) Must Be Delighted With Their 607% Total Return

Feb 16
Shareholders of Senzime (STO:SEZI) Must Be Delighted With Their 607% Total Return

We're Hopeful That Senzime (STO:SEZI) Will Use Its Cash Wisely

Jan 19
We're Hopeful That Senzime (STO:SEZI) Will Use Its Cash Wisely

Are Insiders Buying Senzime AB (publ) (STO:SEZI) Stock?

Dec 23
Are Insiders Buying Senzime AB (publ) (STO:SEZI) Stock?

What Kind Of Investors Own Most Of Senzime AB (publ) (STO:SEZI)?

Nov 26
What Kind Of Investors Own Most Of Senzime AB (publ) (STO:SEZI)?

Revenue & Expenses Breakdown
Beta

How Senzime makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:SEZI Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2336-13412319
30 Sep 2329-13810621
30 Jun 2324-13710622
31 Mar 2319-14310821
31 Dec 2214-1339819
30 Sep 2213-11410317
30 Jun 2211-1048915
31 Mar 2212-867114
31 Dec 2111-826813
30 Sep 2111-745811
30 Jun 2111-665010
31 Mar 218-56398
31 Dec 209-47318
30 Sep 209-412510
30 Jun 209-36239
31 Mar 209-32227
31 Dec 197-33225
30 Sep 197-34290
30 Jun 194-33260
31 Mar 194-30240
31 Dec 183-24201
30 Sep 181-19150
30 Jun 180-16140
31 Mar 180-13130
31 Dec 170-13120
30 Sep 170-13130
30 Jun 171-12130
31 Mar 172-12120
31 Dec 162-9100
30 Sep 161-890
30 Jun 161-880
31 Mar 160-870
31 Dec 150-870
30 Sep 150-760
30 Jun 150-750
31 Mar 150-750
31 Dec 141-650
30 Sep 141-640
30 Jun 141-540
31 Mar 141-540
31 Dec 131-640
30 Sep 130-640
30 Jun 130-640

Quality Earnings: SEZI is currently unprofitable.

Growing Profit Margin: SEZI is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SEZI is unprofitable, and losses have increased over the past 5 years at a rate of 35.7% per year.

Accelerating Growth: Unable to compare SEZI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SEZI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (59.4%).


Return on Equity

High ROE: SEZI has a negative Return on Equity (-35.73%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.